Skip to content

Dexmedetomidine as Adjuvant for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block for Cleft Lip Repair

Comparative Evaluation of Dexamethasone and Dexmedetomidine as Adjuvants for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block in Infants for Cleft Lip Repair

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03480607
Enrollment
44
Registered
2018-03-29
Start date
2017-08-01
Completion date
2018-05-10
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cleft Lip

Brief summary

To assess the efficacy of dexamethasone versus dexmedetomidine as adjuncts to bupivacaine for infra-orbital nerve block in infants undergoing cleft lip surgery.

Detailed description

Regarding patient registry; A prior G power analysis was done. Using the results obtained from previous studies and assuming an alpha error of 0.05 and beta error 0f 0.2 (power of the study 80 %), a sample size of 20 patients per group was calculated. A drop out 10% of cases is expected, so; 22 cases per group will be required. Statistical analysis: Data will be analyzed through SPSS (Statistical Package for Social Sciences). Program version 22. Distribution of data will be first tested by Shapiro test. Data will be presented as mean and standard deviation (SD), median and range or numbers and percentages. For normally distributed data, unpaired t test will be used to compare between mean values of both groups. For pain and sedation scores, Mann Whitney U test will be used. Fisher's exact test will be used for comparison of categorical data. The P value ≤ 0.05 will be considered as the level of statistical significance.

Interventions

DRUGDexmedetomidine group

0.75 ml of 0.5% Bupivacaine in conjunction with 0.5 mcg/kg dexmedetomidine

0.75 ml of 0.5% Bupivacaine in conjunction with 0.1 mcg/kg dexamethasone

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
1 Months to 1 Years
Healthy volunteers
No

Inclusion criteria

* American society of anesthesiologist (ASA) physical status I or II

Exclusion criteria

* known allergy to any of drugs used * coagulopathy * any wound or infection related to puncture site * major illness * failure to gain consent of parents.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative FLACC scalefor 24 hours after surgeryFLACC scale: 0 : relaxed/ comfortable, 1-3 : mild discomfort, 4-6 : moderate discomfort, 7- 10: sever discomfort/ Pain / both,
Postoperative sedation scorefor 4 hours after surgeryThe degree of sedation will be assessed by using a three point sedation scale based on eye opening: - Alert with spontaneous eye opening 0, - Drowsy with eyes only opening in response to speech 1, - Sedated with eyes opening in response to physical stimulation 2,

Secondary

MeasureTime frameDescription
Postoperative nauseafor 24 hours after surgeryAs nausea can't be detected in this age group; so we will detect only if vomiting occur or not and number of attacks.
Heart rateFor 4 hours after induction(beat/min)
Postoperative vomitingfor 24 hours after surgery
Haematoma formation after surgeryfor 24 hours after surgeryThat will be scored as follows; Yes: there is hematoma formation or No: no hematoma formation
Systolic blood pressureFor 4 hours after induction(mmHg)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026